John Q LeonardSep 17, 20142 minA New Model for CollaborationFour strategic recommendations for disruptive innovators in biopharma businesses are as follows: Partner aggressively to develop assets...
John Q LeonardSep 3, 20143 minRoche's Kadcyla Outstrips Marginal Utility in UKAn innovative new cancer drug shown to extend the lives of women with breast cancer by an average of 6 months has recently crossed an...
John Q LeonardAug 20, 20142 minA Climate for DisruptionThe biotech and pharmaceutical industries are currently in the midst of consolidation, and new opportunities for disruption are arising...